Pacciarini MA - Search Results

1

Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.

Pacciarini MA, Barbieri B, Colombo T, Broggini M, Garattini S, Donelli MG. Pacciarini MA, et al. Cancer Treat Rep. 1978 May;62(5):791-800. Cancer Treat Rep. 1978. PMID: 657163

2

In vitro uptake and cytotoxicity of adriamycin in primary and metastatic Lewis lung carcinoma.

Donelli MG, Barbieri B, Erba E, Pacciarini MA, Salmona A, Garattini S, Morasca L. Donelli MG, et al. Among authors: pacciarini ma. Eur J Cancer (1965). 1979 Sep;15(9):1121-9. doi: 10.1016/0014-2964(79)90128-2. Eur J Cancer (1965). 1979. PMID: 527633 No abstract available.

3

Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect.

Donelli MG, Bartosek I, Guaitani A, Martini A, Colombo T, Pacciarini MA, Modica R. Donelli MG, et al. Among authors: pacciarini ma. Cancer Treat Rep. 1976 Apr;60(4):395-401. Cancer Treat Rep. 1976. PMID: 1277213

4

Pharmacodynamic model describing the growth of a mammary carcinoma in the mouse under the influence of adriamycin treatment.

Dagnino G, Donelli MG, Colombo T, Bertello C, Pacciarini MA, Martini A. Dagnino G, et al. Among authors: pacciarini ma. Oncology. 1981;38(1):53-8. doi: 10.1159/000225522. Oncology. 1981. PMID: 7443177

5

Antineoplastic activity and pharmacokinetics of adriamycin and daunomycin in tumor bearing mice.

Martini A, Donelli NG, Mantovani A, Pacciarini MA, Fogar-Ottaviano EF, Morasca L, Garattini S, Spreafico FS. Martini A, et al. Among authors: pacciarini ma. Oncology. 1977;34(4):173-8. doi: 10.1159/000225216. Oncology. 1977. PMID: 917449

6

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer.

Martoni A, Pacciarini MA, Pannuti F. Martoni A, et al. Among authors: pacciarini ma. Eur J Cancer Clin Oncol. 1985 Jul;21(7):803-6. doi: 10.1016/0277-5379(85)90218-4. Eur J Cancer Clin Oncol. 1985. PMID: 3862582

7

Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762).

Vasey PA, Bissett D, Strolin-Benedetti M, Poggesi I, Breda M, Adams L, Wilson P, Pacciarini MA, Kaye SB, Cassidy J. Vasey PA, et al. Among authors: pacciarini ma. Cancer Res. 1995 May 15;55(10):2090-6. Cancer Res. 1995. PMID: 7743508 Clinical Trial.

8

Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients.

Martini A, Moro E, Pacciarini MA, Tamassia V, Natale N, Piazza E. Martini A, et al. Among authors: pacciarini ma. Int J Clin Pharmacol Res. 1984;4(3):231-8. Int J Clin Pharmacol Res. 1984. PMID: 6593309 Clinical Trial.

9

Hemodynamic effects of ceruletide administered intravenously to coronaropathic patients.

Martini A, Pacciarini MA, Binaghi G, Repetto S, Brunetta F. Martini A, et al. Among authors: pacciarini ma. Farmaco Sci. 1982 Aug;37(8):543-7. Farmaco Sci. 1982. PMID: 7128811

10

Pharmacokinetics and bioavailability of metergoline in healthy volunteers after single i.v. and oral administration.

Martini A, Moro E, Marrari P, Pacciarini MA, Sega R, Dell'Osso L, Bertelli A Jr, Tamassia V. Martini A, et al. Among authors: pacciarini ma. Int J Clin Pharmacol Res. 1983;3(1):27-34. Int J Clin Pharmacol Res. 1983. PMID: 6679505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters